Published in Front Neurol on January 06, 2014
Silent arteriovenous malformation hemorrhage and the recognition of "unruptured" arteriovenous malformation patients who benefit from surgical intervention. Neurosurgery (2015) 1.99
Increased CSF biomarkers of angiogenesis in Parkinson disease. Neurology (2015) 1.43
Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. Neuro Oncol (2016) 1.14
Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy. Stroke (2014) 0.89
Intracerebral hemorrhage after intravenous thrombolysis in patients with cerebral microbleeds and cardiac myxoma. Front Neurol (2014) 0.88
Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution. AJNR Am J Neuroradiol (2015) 0.87
Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future. Am J Hypertens (2015) 0.86
Thrombolysis-related intracerebral hemorrhage and cerebral amyloid angiopathy: accumulating evidence. Front Neurol (2015) 0.83
Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods. Neuropsychol Rev (2015) 0.81
Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke. Proc Natl Acad Sci U S A (2015) 0.81
Cerebral small vessel disease and Alzheimer's disease. Clin Interv Aging (2015) 0.80
Cerebral microbleeds are associated with worse cognitive function in the nondemented elderly with small vessel disease. Cerebrovasc Dis Extra (2014) 0.79
Value of brain MRI in infective endocarditis: a narrative literature review. Eur J Clin Microbiol Infect Dis (2015) 0.79
Association study of BUD13-ZNF259 gene rs964184 polymorphism and hemorrhagic stroke risk. Int J Clin Exp Med (2015) 0.77
Accumulation of iron in the putamen predicts its shrinkage in healthy older adults: A multi-occasion longitudinal study. Neuroimage (2015) 0.76
Review And Insights Into The Bleeding Mechanism Incited By Antithrombotic Therapy: Mechanistic Nuances Of Dual Pro-Hemorrhagic Substrate Incorporating Drug-Induced Microvascular Leakage. J Atr Fibrillation (2015) 0.75
Non-neuronal and neuronal BACE1 elevation in association with angiopathic and leptomeningeal β-amyloid deposition in the human brain. BMC Neurol (2015) 0.75
The clinical significance of brain microbleeds in patients with Alzheimer's disease: Preliminary study. Ann Indian Acad Neurol (2016) 0.75
Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives. Korean J Radiol (2016) 0.75
Increased Number and Distribution of Cerebral Microbleeds Is a Risk Factor for Cognitive Dysfunction in Hemodialysis Patients: A Longitudinal Study. Medicine (Baltimore) (2016) 0.75
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
A case of meningococcal meningitis with multiple cerebellar microbleeds detected by susceptibility-weighted imaging. BMC Med Imaging (2015) 0.75
Cerebral microhemorrhages: mechanisms, consequences and prevention. Am J Physiol Heart Circ Physiol (2017) 0.75
The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation. J Neurol (2015) 0.75
Cerebral microbleeds in early Alzheimer's disease. J Neurol (2016) 0.75
Neurologic Complications of Infective Endocarditis: Recent Findings. Curr Infect Dis Rep (2017) 0.75
In Vivo Imaging of Venous Side Cerebral Small-Vessel Disease in Older Adults: An MRI Method at 7T. AJNR Am J Neuroradiol (2017) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med (2012) 8.04
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain (2008) 5.89
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol (2010) 5.76
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol (2010) 5.03
Pathogenesis of leukoaraiosis: a review. Stroke (1997) 4.95
Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science (1990) 4.71
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol (2001) 3.46
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain (2007) 2.93
Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke (2004) 2.92
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain (2007) 2.88
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1984) 2.86
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol (2011) 2.75
Long-term mortality after intracerebral hemorrhage. Neurology (2006) 2.71
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation (2004) 2.67
Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol (2009) 2.67
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol (2008) 2.40
Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke (2007) 2.36
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol (2009) 2.33
Prevalence and severity of microbleeds in a memory clinic setting. Neurology (2006) 2.29
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology (2009) 2.14
Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging (2009) 2.14
Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke (1999) 2.12
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology (1993) 2.12
improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke (2008) 2.09
Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain (2004) 2.07
Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology (2006) 2.06
Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke (2010) 2.04
Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol (2008) 2.03
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology (2010) 2.02
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 1.99
Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke (2012) 1.98
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol (2008) 1.98
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke (2004) 1.96
Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol (2010) 1.96
Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol (2004) 1.95
Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. Stroke (2002) 1.88
Microbleeds versus macrobleeds: evidence for distinct entities. Stroke (2009) 1.83
Clinical significance of microbleeds in subcortical vascular dementia. Stroke (2007) 1.82
Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke (2002) 1.82
Silent intracerebral microhemorrhages in patients with ischemic stroke. Amsterdam Vascular Medicine Group. Ann Neurol (1998) 1.75
Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke (2002) 1.74
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Cerebral microbleeds and cognition in patients with symptomatic small vessel disease. Stroke (2013) 1.72
MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology (1999) 1.71
Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke (2011) 1.70
Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients. Neurology (2004) 1.66
Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry (2010) 1.65
Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol (2008) 1.63
Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology (2012) 1.63
Smoking and risk of hemorrhagic stroke in women. Stroke (2003) 1.63
Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis (2011) 1.63
Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke (2008) 1.59
APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol (2003) 1.53
Superficial siderosis in the general population. Neurology (2009) 1.52
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke (2003) 1.50
A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet (1993) 1.46
Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke (2009) 1.46
Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke (2009) 1.43
11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology (2010) 1.43
Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology (2011) 1.43
Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology (2011) 1.41
Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke (2010) 1.39
Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain (2006) 1.38
Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology (2013) 1.33
Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid. Neuroscience (2006) 1.31
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 1.31
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 1.30
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
A single ascending dose study of bapineuzumab in patients with Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 1.29
Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology (2010) 1.29
Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci (1993) 1.27
Acute management of bleeding in patients on novel oral anticoagulants. Eur Heart J (2012) 1.27
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord (2006) 1.26
Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology (1998) 1.26
Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging (2010) 1.25
Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol (2009) 1.23
Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke (2011) 1.23
Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology (1988) 1.22